Zobrazeno 1 - 5
of 5
pro vyhledávání: '"J Maurice, Hourihane"'
Autor:
Colin P, Derdeyn, Marc I, Chimowitz, Michael J, Lynn, David, Fiorella, Tanya N, Turan, L Scott, Janis, Jean, Montgomery, Azhar, Nizam, Bethany F, Lane, Helmi L, Lutsep, Stanley L, Barnwell, Michael F, Waters, Brian L, Hoh, J Maurice, Hourihane, Elad I, Levy, Andrei V, Alexandrov, Mark R, Harrigan, David, Chiu, Richard P, Klucznik, Joni M, Clark, Cameron G, McDougall, Mark D, Johnson, G Lee, Pride, John R, Lynch, Osama O, Zaidat, Zoran, Rumboldt, Harry J, Cloft, I, Fleming
Publikováno v:
The Lancet. 383:333-341
Summary Background Early results of the Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis trial showed that, by 30 days, 33 (14·7%) of 224 patients in the stenting group and 13 (5·8%) of 227 patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69d10f2e58ba62a16542a031ee8f0c83
https://doi.org/10.1016/s0140-6736(13)62038-3
https://doi.org/10.1016/s0140-6736(13)62038-3
Autor:
Michael J. Lynn, Mark R. Harrigan, Cameron G. McDougall, G. Lee Pride, Richard P. Klucznik, David Fiorella, Andrei V. Alexandrov, Mark D. Johnson, Joni Clark, Colin P. Derdeyn, Zoran Rumboldt, Marc I. Chimowitz, Stanley L. Barnwell, L. Scott Janis, Brian L. Hoh, Tanya N. Turan, David Chiu, Helmi L. Lutsep, Osama O. Zaidat, Michael F. Waters, Elad I. Levy, J. Maurice Hourihane, Harry J. Cloft, Bethany F Lane, Michel T. Torbey
Publikováno v:
Stroke. 43:2682-2688
Background and Purpose— Enrollment in the Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis (SAMMPRIS) trial was halted due to the high risk of stroke or death within 30 days of enrollment in the pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34b89a9ab6368429d046cbbad6ac20ff
https://doi.org/10.1161/strokeaha.112.661173
https://doi.org/10.1161/strokeaha.112.661173
Autor:
Mark R. Harrigan, David Chiu, David Fiorella, Helmi L. Lutsep, Andrei V. Alexandrov, Bethany F Lane, Michel T. Torbey, Michael J. Lynn, Richard P. Klucznik, G. Lee Pride, Mark D. Johnson, Joni Clark, Cameron G. McDougall, Colin P. Derdeyn, Osama O. Zaidat, L. Scott Janis, Brian L. Hoh, Michael F. Waters, Tanya N. Turan, J. Maurice Hourihane, Stanley L. Barnwell, Elad I. Levy, Marc I. Chimowitz, Harry J. Cloft, Zoran Rumboldt
Publikováno v:
New England Journal of Medicine. 365:993-1003
Enrollment was stopped after 451 patients underwent randomization, because the 30-day rate of stroke or death was 14.7% in the PTAS group (nonfatal stroke, 12.5%; fatal stroke, 2.2%) and 5.8% in the medical-management group (nonfatal stroke, 5.3%; no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6248952b143de01a5a146bb1af4afd6
https://doi.org/10.1056/nejmoa1105335
https://doi.org/10.1056/nejmoa1105335
Autor:
J. Maurice Hourihane, Erica Westphal, Michelle Rainka, Vernice Bates, Francis M. Gengo, Maria Janda, Matthew J. Robson
Publikováno v:
Journal of clinical pharmacology. 56(4)
This study demonstrates that patients who are taking 81 mg of aspirin and are nonresponsive benefit from a dose of 162 mg or greater vs a different antiplatelet therapy. We identified 100 patients who were nonresponsive to aspirin 81 mg via whole blo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a9cac6d42e8d8e44203c8e59b56c63b
https://pubmed.ncbi.nlm.nih.gov/26239393
https://pubmed.ncbi.nlm.nih.gov/26239393
Publikováno v:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 6(5)
The factor V Leiden mutation is a specific point mutation in the gene coding for factor V. It renders activated factor V resistant to degradation by activated protein C (APC). This hereditary resistance to APC (HRAPC) is a known risk factor for syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c55933b413d15383a60f82682ef0aae
https://pubmed.ncbi.nlm.nih.gov/17895036
https://pubmed.ncbi.nlm.nih.gov/17895036